
|Articles|January 13, 2020
Charles River and Takeda Announce Collaboration
Advertisement
Charles River has announced a multi-year drug discovery collaboration with Takeda Pharmaceutical Company Limited. Together they will launch multiple integrated programs across Takeda’s four core therapeutic areas with the ultimate goal of delivering preclinical candidates that Takeda can advance into clinical development.
For more information on this collaboration, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
3
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
4
Rethinking Operational Models to Reduce Site Burden in 2026
5



